Table 2 Comparative analysis of combination responses in Dd2 as judged by single point Chou-Talalay analysis for selected drug combinations at IC50 and LD50 concentrations (n = 3, +/āˆ’ SEM values provided in SI) and at the anticipated in vivo concentration (AIVC). Values for HB3 are provided in table S8.

From: High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations

Drug Combination

Avg. FIC

Avg. FICIndex

Avg. FLD

Avg. FLDIndex

Avg. FAIVCa

Avg. FAIVCIndex

Drug A

Drug B

Drug A

Drug B

Drug A

Drug B

ATM + LUM

0.67

0.47

1.1 (Add.)

0.42

0.58

1.0 (Syn.)

ND

ND

ND

ATM + GSK-2126458

0.54

0.52

1.1 (Add.)

0.18

0.21

0.39 (Syn.)

ND

ND

ND

ATM + NVP-BGT226

0.97

1.05

2.0 (Add.)

0.27

0.46

0.93 (Syn.)

0.85

0.14

0.99 (Syn.)

ATM + Torin 2

0.75

0.59

1.3 (Add.)

0.54

0.60

0.94 (Syn.)

ND

ND

ND

LUM + GSK-2126458

0.27

0.40

0.67 (Syn.)

0.20

0.15

0.35 (Syn.)

ND

ND

ND

LUM + NVP-BGT226

0.60

0.93

1.5 (Add.)

1.10

1.17

2.0 (Ant.)

0.45

0.05

0.49 (Syn.)

LUM + Torin 2

0.44

0.48

0.9 (Syn.)

0.50

0.19

0.5 (Syn.)

ND

ND

ND

  1. aData indicates a ratio of ATM:NVP-BGT226 of 100:1 and a ratio of LUM:NVP-BGT226 of 500:1. Additional ratios for ATM:NVP-BGT226 include 50:1, 200:1 and 400:1 and for LUM:NVP-BGT226 include 250:1, 1250:1 and 25000:1. These data are presented in table S8. FIC (fractional inhibitory concentration); FLD (fractional lethal dose); FAIVC (fractional anticipated in vivo concentration); ATM (artemether); LUM (lumefantrine); Add. (additive); Syn. (synergistic); Ant. (antagonistic).